BLA accepted for Priority Review Finerenone (Bayer) Nonsteroidal mineralocorticoid receptor antagonist Treatment of adult patients with heart failure with mildly reduced or preserved ejection fraction ...

The Heart Failure Drugs Market is poised for a transformative decade between 2025 and 2035. As heart failure continues to ...

Researchers have established that both diabetes mellitus (DM) and albuminuria are prevalent in heart failure with preserved ...

Researchers have discovered in a study published in JAMA Cardiology that finerenone offers stable benefits in heart failure ...

The company also announced the appointment of its current Executive Chair, Alvin Shih, MD to the Chief Executive Officer role, plus the appointment of Rebecca Luse, Managing Director at Deep Track ...

Heart failure with preserved ejection fraction (HFpEF) is a disease in which the left ventricle (LV) of the heart shows impaired relaxation during cardiac diastole, often accompanied by structural and ...

The findings from this single-center retrospective study compare outcomes between 2 groups of patients living with connective ...

In this video, Clyde W. Yancy, MD, MSc, MACP, MACC, FAHA, FHFSA, discusses notable updates across several areas of cardiology ...

Corvista Health’s point-of-care device, used to predict pulmonary hypertension (PH), also appears to work well at identifying ...

Cardiac illnesses are among the trickier ones to manage in the limited time provided for many primary care visits, with ...

Findings presented at the American College of Cardiology Annual Scientific Session indicate that finerenone's efficacy in ...

It's especially vital for spotting Heart Failure with preserved Ejection Fraction (HFpEF) - now over half of all heart failure cases - and for monitoring cardiotoxicity in ocology patients undergoing ...